Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 6, 2006
Boston Scientific Corporation (NYSE: BSX) today announced four-year follow-up data from its TAXUS II paclitaxel-eluting stent system...
-
Sep 5, 2006
Initial six-month results show positive outcomes in diabetic patients; safety events for diabetic subset lower than overall patient population
-
Sep 5, 2006
International data suggests low revascularization rates for both TAXUS stent and PROMUS™ (XIENCE™ V) stent
-
Sep 1, 2006
PROMUS Stent joins market-leading TAXUS® Paclitaxel-Eluting Coronary Stent Systems
-
Aug 31, 2006
Results expected to continue to support safety and performance of Boston Scientific's second-generation drug-eluting stent system